CPHI - שולי רווח נקי ממכירות chinapharmaholdings.com

The net margin volume in revenue demonstrates the efficiency of China Pharma Holdings (CPHI), where the -132.80 indicator determines the magnitude of the metric. The business relies on a diversified drug portfolio amid elastic demand in the PRC. Growth is based on partnerships with hospitals to ensure medicine accessibility. Technological progress is evident in the implementation of software robots for analyzing clinical trial data in Asia.
China Pharma Holdings, Inc. (CPHI) - פילוחי מדדים ודוחות פיננסיים

Sales margin is calculated as the ratio of net profit to total revenue. This coefficient determines the efficiency of converting every ruble earned into actual shareholder income. For China Pharma Holdings (CPHI), this metric reflects the ability to neutralize competitors' price dumping by optimizing regional distribution channels. An analysis of net income per unit of sales reveals the business's resilience to government price regulations. The trend on this chart serves as an indicator of the issuer's investment reliability.